Edelman Financial Engines Founder Ric Edelman joins the Yahoo Finance Live panel to discuss how ‘baby bonds’ can help close the racial wealth gap.
Edelman Financial Engines Founder Ric Edelman joins the Yahoo Finance Live panel to discuss how ‘baby bonds’ can help close the racial wealth gap.
The ‘Spring Loaded’ global event will take place at Steve Jobs Theater in Cupertino, California.
"No, I’m not pregnant, despite this VERY realistic pic.”
Pacheedaht First Nation chiefs in Canada tell anti-logging protesters to leave their lands. Leaders condemn ‘unsolicited involvement by others in our territory’ as activists seek to protect old-growth trees
A bidding war between three families has lead to a large, dilapidated house in London’s St. John’s Wood selling for £6.25m.
Eurostat said industrial production in the 19 countries sharing the euro fell 1.0% month-on-month in February for a 1.6% year-on-year drop, compared with market expectations of a 1.1% monthly decline and -0.9% annual reading. The weak output in monthly terms in February was across all categories with the steepest decline of 1.9% for capital goods, 1.2% for energy and 1.1% for durable consumer goods. Capital goods had registered the sharpest increase in January.
ProMediaAuthority has released a set of online marketing tools and services designed to support interior design companies in and around La Jolla, California in their pursuit of media exposure and brand awareness.San Diego, United States, April 14, 2021 (GLOBE NEWSWIRE) -- ProMediaAuthority, an online marketing solutions provider focused on helping local businesses gain exposure, has launched a collection of tools and services tailored to the needs of interior design firms in La Jolla, California and the surrounding area. More details can be found at https://promediaauthority.com/branding The new suite of marketing tools and services builds on the expertise and resources of ProMediaAuthority to level the playing field for La Jolla interior designers. It will help them to increase their online traffic and drive revenue growth through building brand authority and awareness. ProMediaAuthority is offering a set of solutions that allow local interior design businesses to benefit from a multi-channel approach at competitive prices. The company supports its clients’ online marketing strategies by utilizing its access to the most respected media sites that are typically out of reach for smaller firms. The lockdowns and travel restrictions imposed due to the pandemic have led to a surge in the number of remote workers and sharply increased the amount of time people spend at home. With many families opting to redesign their homes to adapt spaces to the new rules of life and work, interior design companies have been afforded an unprecedented opportunity. As vaccine distribution accelerates and restrictions begin to ease, the economy is showing early signs of recovery. Homeowners and businesses are looking for ways to enhance the value of their properties, make better use of existing spaces, or take advantage of tax incentives to make home improvements. In this environment, it is more important than ever for local interior designers to get the exposure and visibility necessary to capture as much business as possible to increase revenue. ProMediaAuthority helps them achieve this through expert branding strategies that seamlessly tie the virtual world to clients’ offline businesses. Headquartered in San Diego, California, ProMediaAuthority specializes in digital marketing solutions for local firms in need of boosting their online visibility and reputation. It develops effective strategies that incorporate new articles published on top media platforms, expert blog content and slideshows posted on leading networks, custom videos, and social media management. Additional information is available at https://www.youtube.com/c/promediaauthority A company representative said, “Our contacts and resources allow us to offer customers exclusive services that are usually only available to large corporations with deep pockets. We are committed to helping interior designers in La Jolla run the most effective marketing campaigns possible and establish enough brand authority to stimulate business growth.” Interested parties can find more information on the services offered by ProMediaAuthority by visiting https://promediaauthority.com/public-relations CONTACT: Name: Denker Sage Organization: ProMediaAuthority Address: 4275 Executive Square Suite 200, San Diego, CA 92037, United States Phone: +1-833-656-3342
Forecasts by Type (Cephalosporins (Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam, Others), Penicillins (Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic Amoxicllin-clavulanic Acid, Amoxil, Others), Fluoroquinolones (Avelox, Cravit, Vigamox, Ciprodex, Cipro/Cirpobay, Geninax, Baxdela, Others), Macrolides (Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin, Others), by Carbapenems (Invanz, Merrem/Meropen, Primaxin, Doribax, Others), Others (Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin)), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, E-Commerce), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Analysis of Leading Drug Discovery Outsourcing Companies.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Antibacterial Drugs Market Report 2020-2030" - https://www.reportlinker.com/p06058458/?utm_source=GNW PLUS, COVID-19 Recovery ScenariosAntibacterial Drugs– our new study reveals trends, R&D progress, and predicted revenues Where is the Antibacterial Drugs market heading? If you are involved in this sector you must read this newly updated report. This report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there. Discover how to stay ahead Our 391 page report provides 231 Tables and 285 Figures. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibacterial Drugs Market. See how to exploit the opportunities. Forecasts to 2030 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market drivers, restraints/challenges, opportunities, PEST, SWOT, and Porter’s Fiver Forces Analysis), company profiles (financials 2015 to 2020, products, recent developments. This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today. Discover sales predictions for the world market and submarkets Global Antibacterial Drugs Market Segmentation By Type • Cephalosporins • Penicillins • Fluoroquinolones • Macrolides • Carbapenems • Others By Cephalosporins • Rocephin • Sulperazon • Ceftin/Zinnat • Meiact • Flomox • Teflaro • Zeftera • Ceftolozane-tazobactam • Ceftazidime-Avibactam By Penicillins • Generic Amoxicillin • Augmentin • Zosyn/Tazocin • Unasyn • Generic amoxicllin-clavulanic acid • Amoxil • Others By Fluoroquinolones • Avelox • Cravit • Vigamox • Ciprodex • Cipro/Cirpobay • Geninax • Baxdela • Others By Macrolides • Biaxin/Clarith • Zithromax • Dalacin • Dificid • Solithromycin • Others By Carbapenems • Invanz • Merrem/Meropen • Primaxin • Doribax • Others By Other Sectors • Zyvox • Cubicin • Tygacil • TOBI/TIP • Solodyn • Vibativ • Sirturo • Tedizolid • Oritavancin • Dalbavancin • Nemonoxacin • Surotomycin • Others By Distribution Channel • Hospital Pharmacies • Drug Stores & Retail Pharmacies In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets: North America • U.S. • Canada Europe • Germany • UK • France • Italy • Spain • Russia • Rest of Europe Asia-Pacific • Japan • China • India • Australia • South Korea • Rest of Asia Pacific Latin America • Brazil • Mexico • Argentina • Rest of LATAM Middle East and Africa • GCC • South Africa • Rest of MEA Leading 15 companies and the potential for market growth Overall world revenue for Antibacterial Drugs Market will surpass US$xx million in 2020, our work calculates. We predict a growth rate of over xx% from 2020 to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Antibacterial Drugs Market report helps you In summary, our 391 pages report provides you with the following knowledge: • Revenue forecasts to 2030 for Antibacterial Drugs Market, with forecasts for Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2030 for 5 regional and 18 key national markets – See forecasts for the Antibacterial Drugs market in North America, Europe, Asia-Pacific, Latin America and MEA. Also, the report provides forecasts for all the major economies such as U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, GCC, and South Africa • Prospects for established firms and those seeking to enter the market– including company profiles for Pfizer Inc., Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, BioVersys AG, Allecra Therapeutics GmbH, Adenium Biotech ApS, Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Inc., AstraZeneca PLC, Allergan, Melinta Therapeutics, SHIONOGI Co., Ltd., and DAIICHI SANKYO COMPANY, LIMITED involved in the Antibacterial Drugs Market. Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence. Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Antibacterial Drugs Market and leading companies. You will find data, trends and predictions.Read the full report: https://www.reportlinker.com/p06058458/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Police say the driver had a lucky escape.
The UK's largest supermarket saw full-year sales soar but the pandemic hit its bottom line.
(Bloomberg) -- The European Union set out its blueprint to raise nearly $1 trillion of debt over five years as it seeks to fund its recovery from the coronavirus pandemic.The bloc is aiming to issue the first debt under its NextGenerationEU stimulus in June and will use a “state of the art” platform to begin selling bonds and bills via a network of primary bank dealers by September, according to the bloc’s executive branch and earlier reported by Bloomberg. Almost a third of the 806 billion euros ($964 billion) will be in green bonds, using a framework of rules to be published in early summer.“The Commission will need to execute financing operations up to EUR 150-200 billion per year over the period to end 2026,” the EU executive said Wednesday. “By June 2021, the Commission will be ready to begin mobilising the funds.”It highlights the ambition of the EU’s first meaningful entry into bond markets, which will see the total of outstanding bonds closing in on that of Spain’s this decade. It also lays the foundation to challenge U.S. Treasuries in coming years as a haven asset, providing a boost to integration in the region and for its common currency.A One-Day Rival to Treasuries Is Born in Europe’s Pandemic BondsBonds will be issued and regularly sold across a range of maturities from between three and 30 years, while there will also be short-dated bills, according to the Commission. It highlighted the latter as a quick way to raise money, at least in the initial phase of the program. The program is 56 billion euros more than initial plans outlined last year that were predicated on 2018 prices.Investors are likely to be keen. The bloc began selling social bonds tied to the funding of a jobs program last year, and those sales have broken global demand records. The EU will begin to issue debt via auction for the first time, as well as syndications via banks. The new platform will be provided by a national central bank that is already used by one of the “large sovereign issuers,” according to the document.The NGEU package includes grants and loans to member states. The loans will have 30-year maturities, with a grace period of 10 years as nations emerge from the crisis.A Rival to Treasuries? EU Bond Binge Raises Prospect: QuickTake(Updates with official announcement.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Nursing Care Market (2020-2025) by Type, Type of Expenditure, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Nursing Care Market is estimated to be USD 1,076.8 Mn in 2020 and is expected to reach USD 1,414.02 Mn by 2025, growing at a CAGR of 5.6%.Market DynamicsKey factors, such as the rising prevalence of diseases along with a growing geriatric population are driving the growth of the nursing care market. Moreover, the need for an efficient healthcare delivery service is likely to support the market growth further.However, the lack of reimbursements for nursing care followed by the high cost of healthcare is restraining the growth of the global nursing care market. Besides, the lack of skilled professionals is also restraining the global nursing care market. A rise in personalized care would develop an opportunity for the growth of the global nursing care market. Market Segmentation The Global Nursing care Market is segmented further based on Type, Type of Expenditure, and Geography.By Service Type, the market is classified as Home Health Care Providers, Nursing Care Facilities, Orphanages & Group Homes, and Retirement Communities. Amongst all, the nursing care facilities are estimated to hold the highest market share.By End-user, the market is classified as Male and Female. Amongst the two, the female segment is estimated to hold the highest market share.By Type of Expenditure, the market is classified as Public and Private. Amongst the two, the private expenditures are estimated to hold the highest market share. By Geography, North America is projected to lead the market. Recent Developments1. Genesis HealthCare has acquired Sun Healthcare Group Inc. The latter provides skilled nursing facilities, assisted and independent living centers, and behavioral health centers in 23 states in the US.- 4th December 20202. Kindred Healthcare, LLC is adding acute inpatient rehabilitation units (ARUs) within the Company's long-term acute care hospitals. The new ARUs will provide intensive, interdisciplinary clinical and rehabilitation services along with 24/7 nursing care. - 16th June 2020 Company ProfilesSome of the key players operating in the global skilled nursing care services market are Golden Living, Emeritus Corporation, Genesis Healthcare., Sunrise Senior Living Inc., LifeCare Centers of America, Brookdale Senior Living, and Extendicare, Inc. Competitive QuadrantThe report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Why buy this report? The report offers a comprehensive evaluation of the Global Nursing Care Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.The report also contains the competitive analysis using IGR Competitive Quadrant, the analyst's proprietary competitive positioning tool. Report Highlights: A complete analysis of the market, including parent industryImportant market dynamics and trendsMarket segmentationHistorical, current, and projected size of the market based on value and volumeMarket shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market Key Topics Covered: 1 Report Description1.1 Study Objectives 1.2 Market Definition1.3 Currency1.4 Years Considered1.5 Language1.6 Key Shareholders2 Research Methodology2.1 Research Process2.2 Data Collection and Validation2.2.1 Secondary Research2.2.2 Primary Research2.3 Market Size Estimation2.4 Assumptions of the Study2.5 Limitations of the Study3 Executive Summary4 Market Overview4.1 Introduction 4.2 Market Dynamics4.2.1 Drivers18.104.22.168 Increasing prevalence of various diseases coupled with an ageing population22.214.171.124 Need for an efficient healthcare delivery service 4.2.2 Restraints126.96.36.199 Lack of reimbursements188.8.131.52 High cost of services184.108.40.206 Lack of skilled professionals4.2.3 Opportunities220.127.116.11 Technological advancements18.104.22.168 Rise in the demand for personalized care services4.2.4 Challenges22.214.171.124 Inadequate staffing levels126.96.36.199 Rise in the home healthcare sector4.3 Trends5 Market Analysis5.1 Porter's Five Forces Analysis5.2 Impact of COVID-195.3 Ansoff Matrix Analysis6 Global Nursing Care Market, By Service Type6.1 Introduction6.2 Home Health Care Providers6.3 Nursing Care Facilities6.4 Orphanages & Group Homes6.5 Retirement Communities7 Global Nursing Care Market, By End User7.1 Introduction7.2 Male7.3 Female8 Global Nursing Care Market, By Type of Expenditure8.1 Introduction8.2 Public8.3 Private9 Global Nursing Care Market, By Geography9.1 Introduction9.2 North America188.8.131.52 US184.108.40.206 Canada220.127.116.11 Mexico9.3 South America18.104.22.168 Brazil22.214.171.124 Argentina9.4 Europe126.96.36.199 UK188.8.131.52 France184.108.40.206 Germany220.127.116.11 Italy18.104.22.168 Spain22.214.171.124 Rest of Europe9.5 Asia-Pacific126.96.36.199 China188.8.131.52 Japan184.108.40.206 India220.127.116.11 Indonesia18.104.22.168 Malaysia22.214.171.124 South Korea126.96.36.199 Australia188.8.131.52 Russia184.108.40.206 Rest of APAC9.6 Rest of the World220.127.116.11 Qatar18.104.22.168 Saudi Arabia22.214.171.124 South Africa126.96.36.199 United Arab Emirates188.8.131.52 Latin America10 Competitive Landscape10.1 IGR Competitive Quadrant10.2 Market Share Analysis10.3 Competitive Scenario10.3.1.1 Mergers & Acquisitions10.3.1.2 Agreement, Collaborations, & Partnerships10.3.1.3 New Product Launches & Enhancements10.3.1.4 Investments & Funding11 Company Profiles11.1 Emeritus (Brookdale)11.2 Genesis Healthcare11.3 Life Care Centers for America11.4 Kindred Healthcare (Humana and PE firms)11.5 Extendicare11.6 Apria Healthcare Group Inc. (Blackstone Group)11.7 Golden Living11.8 Sunrise Senior Living Inc11.9 Brookdale Senior Living11.10 Gentiva (Kindred Healthcare)11.11 Lincare (Linde)11.12 CVS Caremark11.13 Amedisys, Inc. 11.14 Infinity HomeCare (Amedisys Inc)11.15 Vintage Senior Living11.16 Kaiser Permanente11.17 The Ensign Group, Inc.11.18 EHHI Holdings, Inc.(HealthSouth Corporation)11.19 Memorial Sloan Kettering11.20 Bayshore HealthCare11.21 CBI Health Group11.22 Trinity Health11.23 Ambercare (Addus HomeCare)12 Appendix12.1 QuestionnaireFor more information about this report visit https://www.researchandmarkets.com/r/gkykly CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The 50-year-old model has received her warrant card and police badge after qualifying as a Special Constable.
Even as Tokyo unveiled installations featuring the Olympic rings and mascots to celebrate the 100-day milestone, organisers face monumental challenges as virus surges.
A gang is demanding $1m in ransom for 10 people, most of them clergy, kidnapped on Sunday.
The "Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
Forecasts by Technology (Augmented Reality, Virtual Reality), Vertical (Commercial Aviation, Military Aviation), Device (Head Mounted Display, Head-up Display, Handheld Device, Gesture Tracking Device), End-user (Operations (MRO, OEM, Airlines, Aircraft, Airports), Training (Crew & Ground Support Staff, Engineers, Pilots)).New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Augmented Reality and Virtual Reality in Aviation Market Report 2020-2030" - https://www.reportlinker.com/p06058461/?utm_source=GNW PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis• Do you need definitive augmented reality and virtual reality in aviation market data? • Succinct Augmented reality and virtual reality in aviation market analysis? • Technological insight? • Clear competitor analysis? • Actionable business recommendations? Read on to discover how this definitive report can transform your own research and save you time. The recent developments in Augmented reality and virtual reality in aviation technologies, has led the analyst to publish this timely report. The $xyz million Augmented reality and virtual reality market is expected to flourish in the next few years because of demand for higher efficiency and cost saving in aviation and usefulness of the technology in imparting training to pilots, crew, engineers, among others in lesser cost. Report highlights • More than 150 quantitative tables, charts, and graphs Analysis of key players in Augmented reality and virtual reality market players • Alphabet • EON Reality • HTC • Magic Leap • Microsoft • Skylights Aero • PTC • Honeywell International • Sony • Facebook (Oculus VR) • Global Augmented reality and virtual reality market outlook and analysis from 2020-2030 Augmented reality and virtual reality forecasts and analysis from 2020-2030 • Technology including augmented reality and virtual reality • End user including training and operations • Device including Head Mounted Display, Head-Up Display, Handheld Device, Gesture Tracking Device • Vertical including commercial aviation and military aviation Regional Augmented reality and virtual reality market forecasts from 2020-2030 • North America forecast 2020-2030 • Asia Pacific forecast 2020-2030 • Europe forecast 2020-2030 • Middle East forecast 2020-2030 Key questions answered • What does the future hold for the augmented reality and virtual reality for aviation industry? • Where should you target your business strategy? • Which applications should you focus upon? • Which disruptive technologies should you invest in? • Which companies should you form strategic alliances with? • Which company is likely to success and why? • What business models should you adopt? • What industry trends should you be aware of? Target audience • Leading Augmented reality and virtual reality companies • Suppliers • Contractors • Technologists • R&D staff • Consultants • Analysts • CEO’s • CIO’s • COO’s • Business development managers • Investors • Governments • Agencies • Industry organizations • BanksRead the full report: https://www.reportlinker.com/p06058461/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, and Distribution Channel, and Geography" report has been added to ResearchAndMarkets.com's offering. According to this report the global multiple sclerosis therapeutics market is expected to reach US$ 39,223.59 million by 2027 from US$ 24,026.90 million in 2019. The market is estimated to grow at a CAGR of 6.5% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Based on drug class, the market is segmented into immunosuppressant and immunomodulators. In 2019, the immunomodulators segment accounted for larger share of the market. Growth of this segment is attributed to launch of new generic drugs and increase in adoption of immunomodulators in multiple sclerosis (MS) treatment. The immunosuppressant segment is likely to register higher CAGR during the forecast period. Based on route of administration, the multiple sclerosis therapeutics market is segmented into injectable and oral. The injectable segment held larger share of the market in 2019, and same segment is anticipated to register higher CAGR during the forecast period. Based on distribution channel, the multiple sclerosis therapeutics market is segmented into hospital pharmacies, retail pharmacies, and e-commerce. The hospital pharmacies segment held the largest share of the market in 2019, and the e-commerce segment is anticipated to register the highest CAGR in the market during the forecast period. COVID-19 pandemic has become the most significant challenge across the world. This would be difficult, especially for developing countries across the globe, as it may lead to reduction in imports due to disruptions in global trade. Till date, no definitive treatment against COVID-19 has been established. Patients with severe health conditions, such as neurological diseases, are witnessing delays in treatment. Supply chain disruptions associated with this pandemic situation would ultimately affect the sales of products for a short period. However, the supply of MS drugs has been continuous in the pandemic as pharmacies are allowed to stay open during the lockdown. Several companies are cutting their clinical trial activities and delaying product launches in response to the COVID-19 pandemic. For instance, Bristol-Myers Squibb delayed the launch of its multiple-sclerosis drug Zeposia (ozanimod) due to the COVID-19 pandemic. Merck & Co., Inc.; Novartis AG; Bayer AG; Sanofi; Bristol-Myers Squibb Company; Horizon Therapeutics plc.; Teva Pharmaceutical Industries Ltd; Takeda Pharmaceutical Company Limited; F. Hoffmann-La Roche Ltd., and Biogen are among the leading companies operating in the multiple sclerosis therapeutics market. The report segments global multiple sclerosis therapeutics market as follows:By Drug Class ImmunosuppressantImmunomodulators By Route of Administration InjectableOral By Distribution Channels Hospital PharmaciesRetail PharmaciesE-Commerce By Geography North AmericaUSCanadaMexicoEuropeFranceGermanyItalyUKSpainRest of EuropeAsia Pacific (APAC)ChinaIndiaSouth KoreaJapanAustraliaRest of Asia PacificMiddle East & Africa (MEA)South AfricaSaudi ArabiaUAERest of Middle East & AfricaSouth America (SAM)BrazilArgentinaRest of South America Reasons to Buy Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Multiple Sclerosis Therapeutics market.Highlights key business priorities in order to assist companies to realign their business strategies.The key findings and recommendations highlight crucial progressive industry trends in the global Multiple Sclerosis Therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution. Key Topics Covered: 1. Introduction1.1 Scope of the Study1.2 Research Report Guidance1.3 Market Segmentation1.3.1 Global Multiple Sclerosis Therapeutics Market - By Drug Class1.3.2 Global Multiple Sclerosis Therapeutics Market - By Route Of Administration1.3.3 Global Multiple Sclerosis Therapeutics Market - By Distribution Channel1.3.4 Global Multiple Sclerosis Therapeutics Market - By Geography2. Multiple Sclerosis Therapeutics Market - Key Takeaways3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research4. Global Multiple Sclerosis Therapeutics- Market Landscape4.1 Overview4.2 PEST Analysis4.2.1 North America - PEST Analysis4.2.2 Europe - PEST Analysis4.2.3 Asia Pacific - PEST Analysis4.2.4 Middle East and Africa (MEA) - PEST Analysis4.2.5 South and Central America (SCAM) - PEST Analysis4.1 Expert Opinions5. Multiple Sclerosis Therapeutics Market - Key Market Dynamics5.1 Market Drivers5.1.1 Growing Prevalence of Multiple Sclerosis (MS)5.1.2 Rising Funding for Multiple Sclerosis Research5.2 Market Restraints5.2.1 High Cost of Multiple Sclerosis Treatment5.3 Market Opportunities5.3.1 Increasing Awareness About Multiple Sclerosis5.4 Future Trends5.4.1 Development and Launch of Innovative Products5.5 Impact analysis6. Multiple Sclerosis Therapeutics Market - Global Analysis6.1 Global Multiple Sclerosis Therapeutics Market Revenue Forecast And Analysis6.2 Global Multiple Sclerosis Therapeutics Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players7. Multiple Sclerosis Therapeutics Market Analysis - By Drug Class7.1 Overview7.2 Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)7.3 Immunosuppressant7.3.1 Overview7.3.2 Immunosuppressant: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)7.4 Immunomodulators7.4.1 Overview7.4.2 Immunomodulators: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)8. Multiple Sclerosis Therapeutics Market Analysis - By Route of Administration8.1 Overview8.2 Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)8.3 Injectable8.3.1 Overview8.3.2 Injectable: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)8.4 Oral8.4.1 Overview8.4.2 Oral: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)9. Multiple Sclerosis Therapeutics Market Analysis - By Distribution Channel9.1 Overview9.2 Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 20279.3 Hospital Pharmacies9.3.1 Overview9.3.2 Hospital Pharmacies: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)9.4 Retail Pharmacies9.4.1 Overview9.4.2 Retail Pharmacies: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)9.5 E-Commerce9.5.1 Overview9.5.2 E-Commerce: Multiple Sclerosis Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)10. Multiple Sclerosis Therapeutics Market Analysis And Forecast To 2027 - Geographical Analysis10.1 North America: Multiple Sclerosis Therapeutics Market10.2 Europe: Multiple Sclerosis Therapeutics Market10.3 Asia Pacific Multiple Sclerosis Therapeutics Market Revenue And Forecasts To 202710.4 Middle East & Africa Multiple Sclerosis Therapeutics Market Revenue And Forecasts To 202710.5 South and Central America: Multiple Sclerosis Therapeutics Market11. Impact of COVID-19 Pandemic on Global Multiple Sclerosis Therapeutics Market11.1 North America: Impact Assessment of COVID-19 Pandemic11.2 Europe: Impact Assessment Of COVID-19 Pandemic11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic11.5 South & Central America: Impact Assessment of COVID-19 Pandemic12. Industry Landscape12.1 Overview12.2 Growth Strategies Done by the Companies in the Market, (%)12.3 Organic Developments12.3.1 Overview12.4 Inorganic Developments12.4.1 Overview13. Company Profiles13.1 Merck & Co., Inc.13.1.1 Key Facts13.1.2 Business Description13.1.3 Products and Services13.1.4 Financial Overview13.1.5 SWOT Analysis13.1.6 Key Developments13.2 Novartis AG13.2.1 Key Facts13.2.2 Business Description13.2.3 Products and Services13.2.4 Financial Overview13.2.5 SWOT Analysis13.2.6 Key Developments13.3 Bayer AG13.3.1 Key Facts13.3.2 Business Description13.3.3 Products and Services13.3.4 Financial Overview13.3.5 SWOT Analysis13.3.6 Key Developments13.4 Sanofi13.4.1 Key Facts13.4.2 Business Description13.4.3 Products and Services13.4.4 Financial Overview13.4.5 SWOT Analysis13.4.6 Key Developments13.5 Bristol-Myers Squibb Company13.5.1 Key Facts13.5.2 Business Description13.5.3 Products and Services13.5.4 Financial Overview13.5.5 SWOT Analysis13.5.6 Key Developments13.6 Horizon Therapeutics plc13.6.1 Key Facts13.6.2 Business Description13.6.3 Products and Services13.6.4 Financial Overview13.6.5 SWOT Analysis13.6.6 Key Developments13.7 TEVA PHARMACEUTICAL INDUSTRIES LTD13.7.1 Key Facts13.7.2 Business Description13.7.3 Products and Services13.7.4 Financial Overview13.7.5 SWOT Analysis13.7.6 Key Developments13.8 Takeda Pharmaceutical Company Limited13.8.1 Key Facts13.8.2 Business Description13.8.3 Products and Services13.8.4 Financial Overview13.8.5 SWOT Analysis13.8.6 Key Developments13.9 F. HOFFMANN-LA ROCHE LTD.13.9.1 Key Facts13.9.2 Business Description13.9.3 Products and Services13.9.4 Financial Overview13.9.5 SWOT Analysis13.9.6 Key Developments13.10 Biogen13.10.1 Key Facts13.10.2 Business Description13.10.3 Products and Services13.10.4 Financial Overview13.10.5 SWOT Analysis13.10.6 Key Developments14. AppendixFor more information about this report visit https://www.researchandmarkets.com/r/yb5oto CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Practicing Islam was banned in Spain after the Catholic conquest but recent discoveries prove that Muslims continued eating traditions in secret.
As a dad, he gets so many comments, so many swoony looks and so many large smiles – as he does exactly the same as I’m doing
Uroosa Arshid hopes to inspire other Muslim women to follow in her footsteps.